Intelligence · Clinical Development
Pipeline search results
Programs matching “oxaliplatin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 23 pipeline programs matching "oxaliplatin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Oxaliplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rectal Neoplasms
1 trial -
Oxaliplatin
The First People's Hospital of Lianyungang
Rectal Cancer
1 trial -
Panitumumab-3001
Takeda
Colorectal Cancer
1 trial -
SL-B2022-793-01
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
Art-BTC
Hospital Authority, Hong Kong
Biliary Cancer Metastatic
1 trial -
Bevacizumab combined with Oxaliplatin and TAS-102
The First People's Hospital of Lianyungang
Advanced Colorectal Cancer
1 trial -
CAPECITABINE , OXALIPLATIN
Disc Medicine
Patients with early-stage rectal cancer (defined as early rectal cancer cT1-3abN0M0 or early-intermediate rectal cancer cT1-3abN1(≤3 nodes ≤8mm)M0
1 trial -
Capecitabine-Oxaliplatin-Irinotecan Combination
The First People's Hospital of Lianyungang
Unresectable Metastatic Colorectal Cancer
1 trial -
Gemcitabine Oxaliplatin 5FU and Leucovorin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatic Cancer
1 trial -
LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy
The George Institute
Colon cancer
1 trial -
LOTS-GC-01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
Mektovi film-coated tablets for metastatic colorectal cancer wi…
Disc Medicine
metastatic colorectal cancer with a proven RAS mutation after failure of standard systemic treatment regimens including at least 5- FU/capecitabine-oxaliplatin and irinotecan based standard treatment (unless contra-indications for either oxaliplatin or irinotecan)
1 trial -
Oxaliplatin
Universal Integrated
Previously Treated Metastatic Non-Small Cell Lung Cancer
1 trial -
Oxaliplatin
Sanofi Pasteur
Uterine Neoplasms
1 trial -
Oxaliplatin
Regeneron UK Limited
Colorectal Cancer
1 trial -
Panitumumab-2003
Takeda
Colorectal Carcinoma
1 trial -
TEMOZOLOMIDE , IRINOTECAN
Fondazione Telethon ETS
Stage II (pT4)/III colorectal cancer with positive circulating tumor DNA (ctDNA) after oxaliplatin-based adjuvant chemotherapy
1 trial -
UC-GIG-2311
Ningbo Cancer Hospital
Fluoropyrimidine (FP)-naive patients with gastrointestinal (GI) cancer and available pre-treatment uracilemia ([U]) starting chemotherapy combining FP (5FU or capecitabine) and oxaliplatin for any indication
1 trial -
anlotinib +TQB2450 + Oxaliplatin+S-1
The First People's Hospital of Lianyungang
Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
1 trial -
gemcitabine and oxaliplatin.
The First People's Hospital of Lianyungang
Gallbladder Carcinoma
1 trial -
oxaliplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stomach Neoplasms
1 trial -
cisplatin oxaliplatin tegafur
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
OXALIPLATIN, CAPECITABINE
Disc Medicine
Locally advanced or metastatic gastro-intestinal carcinoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.